Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThese are generic site maintenance updates and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedA glossary feature was added to the page. In addition, several metadata labels and the revision information were updated, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' and the revision moved from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter update: Revision: v3.3.3 added and the HHS Vulnerability Disclosure link removed; the prior Revision: v3.3.2 is no longer listed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe Publications section includes a new note that publications are automatically filled from PubMed. The revision line updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.